Deborah Cannon - Concepedia

Author

Deborah Cannon

Centers for Disease Control and Prevention

Also Known As

D Cannon, D L Cannon, D. CANNON, D. Cannon, D. L. CANNON, Deborah Cannon, Deborah L Cannon, Deborah L. Cannon, Jennifer Brown

Publications

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention Emory University Veterans Health Administration Uganda Virus Research Institute University of Georgia

About

Deborah Cannon is an author at Centers for Disease Control and Prevention specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	23	3.4K
2	Natural Sciences	4	4	969
3	Public Health	3	3	384
4	Biochemistry	3	3	275
5	Allergy	2	2	389

Deborah Cannon

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 Fiona P. Havers, Carrie Reed, Travis Lim, JAMA Internal Medicine	2020	739
Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats Jonathan S. Towner, Brian R. Amman, Tara K. Sealy, PLoS Pathogens Virus TransmissionPathogen DiscoveryEgyptian Fruit BatsVirus PhylogenyParasitology	2009	694
Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection Brian R. Amman, Serena A. Carroll, Zachary Reed, PLoS Pathogens	2012	439
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides Raymond F. Schinazi, Robert M. Lloyd, M. Hong Nguyen, Antimicrobial Agents and Chemotherapy Human Immunodeficiency VirusesImmunologyPharmacotherapyAntiviral DrugDrug Resistance	1993	367
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine Raymond F. Schinazi, A. McMillan, Deborah Cannon, Antimicrobial Agents and Chemotherapy Selective InhibitionRacemic FtcMedicinal ChemistryMedicineHuman Immunodeficiency Viruses	1992	290
Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes Raymond F. Schinazi, C. K. CHU, A Peck, Antimicrobial Agents and Chemotherapy ImmunologyPharmacotherapyOptical IsomersAntiviral DrugHuman Lymphocytes	1992	264
Anthraquinones as a new class of antiviral agents against human immunodeficiency virus R. F. SCHINAZI, Chung K. Chu, Janga Ramesh Babu, Antiviral Research Antiviral AgentsMedicineImmunologyAntiviral Drug DevelopmentAntiviral Therapy	1990	178
Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1 Raymond F. Schinazi, J P Sommadossi, Vanessa Saalmann, Antimicrobial Agents and Chemotherapy ImmunologyAntiviral DrugRelative Antiviral PotenciesMedicinal Chemistry3'-Azido-3'-deoxythymidine Nucleotide Dimers	1990	173
Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011–2014 Md Saiful Islam, Hossain M. S. Sazzad, Syed Moinuddin Satter, Emerging infectious diseases Nipah Virus TransmissionEmerging Infectious DiseasesGlobal HealthPathogenesisNipah Virus	2016	163
Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda Adam MacNeil, Eileen C. Farnon, Joseph Francis Wamala, Emerging infectious diseases Infectious Disease EpidemiologyPathogen PrevalenceVirus EpidemiologyEmerging Infectious DiseasesGlobal Health	2010	143

Page 1